2157 — Lepu Biopharma Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$8.21bn
- HK$8.48bn
- CNY225.35m
Annual cashflow statement for Lepu Biopharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -515 | -613 | -1,029 | -699 | -30.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 253 | 170 | 198 | 86.4 | -343 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -20.6 | -63.7 | 114 | 36.7 | 19.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -234 | -423 | -622 | -481 | -251 |
| Capital Expenditures | -364 | -311 | -220 | -115 | -41.2 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -51.5 | -439 | 216 | 40.8 | 59.5 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -415 | -750 | -3.89 | -74.7 | 18.3 |
| Financing Cash Flow Items | 330 | 0.805 | -11.1 | -56 | -30.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 770 | 1,387 | 380 | 1,032 | -11 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 121 | 214 | -248 | 514 | -243 |